Dova Pharmaceuticals Inc.

CIK 1685071 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dova Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Nov 22, 201915-12B0000950157-19-001353
Nov 18, 2019EFFECT9999999995-19-002592
Nov 18, 2019SC 13G/A0001193125-19-293583
Nov 15, 201940000899243-19-027440
Nov 12, 2019SC TO-T/A0000950157-19-001296
Nov 12, 201940001209191-19-056045
Nov 12, 2019S-8 POS0000950157-19-001301
Nov 12, 201940001209191-19-056046
Nov 12, 201940001209191-19-056024
Nov 12, 201940001209191-19-056025
Nov 12, 2019S-8 POS0000950157-19-001302
Nov 12, 201940001209191-19-056047
Nov 12, 201910-Q0001685071-19-000029
Nov 12, 20198-K0000950157-19-001299
Nov 12, 201940001209191-19-056038
Nov 12, 201940001209191-19-056020
Nov 12, 201940001209191-19-056036
Nov 12, 2019POS AM0000950157-19-001303
Nov 12, 2019SC 14D9/A0000950157-19-001300
Nov 12, 201940001209191-19-056030
Nov 12, 201940001209191-19-056032
Nov 12, 201925-NSE0001354457-19-000597
Nov 12, 201940001209191-19-056042
Nov 1, 2019SC TO-T/A0000950157-19-001236
Nov 1, 2019SC 14D9/A0001104659-19-059029